| Literature DB >> 2735519 |
K Osterman1, A M Norborg, E Stähl.
Abstract
Nineteen patients with asthma completed an open, randomized, crossover study in which 0.5 mg terbutaline sulphate was administered either via Turbuhaler or via the metered dose inhaler (MDI) for 2-week periods. The clinical effect of the two treatment forms was comparable; both provided adequate bronchodilator therapy. Patients also considered Turbuhaler and MDI equally effective, with a small preference for the MDI. Turbuhaler seems to be a valuable alternative to bronchodilator MDI therapy.Entities:
Mesh：
Substances：
Year: 1989 PMID： 2735519 DOI： 10.1111/j.1398-9995.1989.tb01073.x
Source DB: PubMed Journal: Allergy ISSN： 0105-4538 Impact factor: 13.146